Articles in section Licensing
| << Joint Venture | 344 articles | Mergers & Acquisitions >> |
| Next >> |
-
Merck & Co. Out-Licenses Second CNS Programme to Cerecor
-
Dainippon Sumitomo Licenses Japanese Rights to Two Redox-Directed Drugs from Edison Pharmaceuticals
-
Lundbeck and Otsuka Expand Alliance with Deal for Late-Stage Alzheimer’s Disease Programme
-
NPS Pharmaceuticals Regains Global Rights to Two Orphan Drugs from Takeda
-
AbbVie Licenses Phase II-Ready Antibody Programme to Receptos for Development in Eosinophilic Oesophagitis
-
Resolve Therapeutics Secures Path to Liquidity via Option Deal with Takeda
-
Jazz and Concert Collaborate to Develop Deuterium-Modified Version of Xyrem®
-
Roche Licenses Chiasma’s Late-Stage Oral Acromegaly Therapy
-
Biocon Finds a New Partner for its Biosimilar Insulin Analogues in Mylan
-
Reckitt Benckiser Licenses Seven OTC Brands from BMS in Latin America



RSS